The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase
Abstract
Recently, pegylated arginine deiminase (ADI; EC 3.5.3.6) has been used to treat the patients with hepatocellular carcinoma or melanoma, in which the level of argininosuccinate synthetase (ASS) activity is low or undetectable. The efficacy of its antitumor activity largely depends on the level of intracellular ASS, which enables tumor cells to recycle citrulline to arginine. Thus, we examined the expression levels of ASS in various cancer cells and found that it is low in renal cell carcinoma (RCC) cells, rendering the cells highly sensitive to arginine deprivation by ADI treatment. Immunohistochemical analysis revealed that in biopsy specimens from RCC patients (n = 98), the expression of ASS is highly demonstrated in the epithelium of normal proximal tubule but not seen in tumor cells. Furthermore, RCC cells treated with ADI showed remarkable growth retardation in a dose dependent manner. ADI also exerted in vivo antiproliferative effect on the allografted renal cell carcinoma (RENCA) tumor cells and prolonged the survival of tumor-bearing mice. Histological examination of the tumors revealed that tumor angiogenesis and vascular endothelial growth factor (VEGF) expression were significantly diminished by ADI administration. Therefore, these findings suggest that arginine deprivation by ADI could provide a beneficial strategy for the treatment of RCC in ways of inhibitions of arginine availability and neovascularization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intriguingly, both ASS1 and ASL enzymes are frequently epigenetically silenced in melanoma, renal cell carcinoma and hepatocellular carcinoma (Bowles et al., 2008; Ensor et al., 2002; Yoon et al., 2007).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Yoon et al., 2007
Citations
Cites
Multiple Comparisons Using Rank Sums
Dunn, O. J. (1964) · Technometrics · doi:10.1080/00401706.1964.10490181 · Cited by 5,168
Papapetropoulos, A., García‐Cardeña, G., Madri, J. A., & Sessa, W. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119868 · Cited by 1,195
Protein A, avidin, and biotin in immunohistochemistry.
Hsu, S. M., & Raine, L. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.11.6172466 · Cited by 638
Enzymes of Arginine Metabolism
Morris, S. M. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2743s · Cited by 361
Incidence and distribution of argininosuccinate synthetase deficiency in human cancers
Dillon, B. J., Prieto, V. G., Curley, S. A., Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2004) · Cancer · doi:10.1002/cncr.20057 · Cited by 317
Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315
Sasaki, K., Hattori, T., Fujisawa, T., Takahashi, K., Inoue, H., & Takigawa, M. (1998) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021955 · Cited by 272
Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250
Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238
Relative importance of kidney and liver in synthesis of arginine by the rat
Featherston, W. R., Rogers, Q. R., & Freedland, R. (1973) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1973.224.1.127 · Cited by 186
Cited by
Sorted by citations
Items 101–165 of 165
Mono-PEGylation of a Thermostable Arginine-Depleting Enzyme for the Treatment of Lung Cancer
Chung, S., Kim, C.-F., Kwok, S.-Y., Tam, S.-Y., Chen, Y. W., Chong, H.-C., Leung, S.-L., So, P., Wong, K., Leung, Y., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124234 · Cited by 16
Stelter, L., Evans, M. J., Jungbluth, A. A., Longo, V. A., ZANZONICO, P. B., Ritter, G., Bomalaski, J. S., Old, L. J., & Larson, S. M. (2013) · PubMed · Cited by 14
Kim, Y., Kobayashi, E., Kubota, D., Suehara, Y., Mukaihara, K., Akaike, K., Ito, A., Kaneko, K., Chuman, H., Kawai, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12225 · Cited by 14
Roeksomtawin, S., Navasumrit, P., Waraprasit, S., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Savaraj, N., & Ruchirawat, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8807 · Cited by 14
Calderón‐Montaño, J. M., Guillén-Mancina, E., Jiménez‐Alonso, J. J., Jiménez-González, V., Burgos‐Morón, E., Mate, A., Pérez-Guerrero, M. C., & López‐Lázaro, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416132 · Cited by 14
Yang, J., Miao, D., Li, X., Zhao, C., Tan, D., Wu, S., Lu, F., Shi, J., Lv, Q., Ruan, H., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1664292 · Cited by 15
Glazer, E. S., Kaluarachchi, W. D., Massey, K. L., Zhu, C., & Curley, S. A. (2010) · Surgery · doi:10.1016/j.surg.2010.03.022 · Cited by 13
Kaur, B., & Kaur, R. (2015) · Protein Expression and Purification · doi:10.1016/j.pep.2015.09.011 · Cited by 12
Walts, A. E., Bomalaski, J. S., Ines, D., & Oršulić, S. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1904-z · Cited by 12
Arginine enzymatic deprivation and diet restriction for cancer treatment
Zam, W. (2017) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902017000300200 · Cited by 12
Borlak, J. T., Singh, P., & Gazzana, G. (2015) · BMC Genomics · doi:10.1186/s12864-015-1312-z · Cited by 12
Sun, P., Zhu, X., Shrubsole, M. J., Ness, R. M., Hibler, E. A., Cai, Q., Long, J., Chen, Z., Li, G., Hou, L., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.04.016 · Cited by 11
Exploring molecular and cellular mechanisms of Pre-Metastatic niche in renal cell carcinoma
Zhou, X., Li, R., Lai, M., & Lai, C. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02315-9 · Cited by 12
Yang, H., Lin, M. T., Xiong, F., Yang, Y. P., Nie, X., & Zhou, R. L. (2009) · Oncology Letters · doi:10.3892/ol_00000005 · Cited by 10
Sharma, A., Bala, K., & Husain, I. (2017) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2017.09.001 · Cited by 10
Promiscuous Anticancer Drugs from Pathogenic Bacteria: Rational Versus Intelligent Drug Design
Fialho, A. M., & Chakrabarty, A. M. (2010) · Wiley eBooks · doi:10.1002/9780470626528.ch8 · Cited by 11
Zaki, M. E. A., Al‐Hussain, S. A., Al‐Mutairi, A. A., Samad, A., Ghosh, A., Chaudhari, S., Khatale, P. N., Ajmire, P. V., & Jawarkar, R. D. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1129997 · Cited by 9
Cheng, S. M., Shieh, M., Lin, T., & Cheung, C. H. A. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30555 · Cited by 10
Wu, F. L., Liang, Y.-F., Chang, Y.-C., Yo, H.-H., Wei, M., & Shen, L. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-25 · Cited by 9
Targeting Metabolic Pathways in Kidney Cancer
Hoerner, C. R., Miao, S. Y., Hsieh, J. J.-D., & Fan, A. C. (2020) · The Cancer Journal · doi:10.1097/ppo.0000000000000472 · Cited by 9
Simultaneous analysis of citrulline and arginine in serum and tissue
Mao, H.-M., Chen, B.-G., Wang, W.-M., Zhuang, P., Zong, M., & Xu, Z. (2010) · Microchemical Journal · doi:10.1016/j.microc.2010.10.001 · Cited by 8
Mavedatnia, D., Tran, J., Oltean, I. I., Bijelić, V., Moretti, F. M., Lawrence, S. L., & Demellawy, D. E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235693 · Cited by 8
Human arginase I: a potential broad-spectrum anti-cancer agent
Anakha, J., Prasad, Y. R., Sharma, N., & Pande, A. H. (2023) · 3 Biotech · doi:10.1007/s13205-023-03590-3 · Cited by 9
Engineering Of Therapeutic Proteins
Zhao, H., Rubin-Pitel, S. B., & Wen, F. (2009) · CRC Press eBooks · doi:10.1201/9781420076592.ch7 · Cited by 7
Harten, S. K., Esteban, M. A., & Maxwell, P. H. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2008.12.005 · Cited by 7
Xie, J., Ni, F., Shao, J., Zhang, D., Guo, T., & Wang, X. W. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218244 · Cited by 6
Murali, R., & Gopalakrishnan, A. V. (2023) · Medical Oncology · doi:10.1007/s12032-023-02225-0 · Cited by 7
Cancer therapies based on enzymatic amino acid depletion
Teixeira, C. S. S., Fernandes, H. S., Fernandes, P. A., Ramos, M. J., & Cerqueira, N. M. F. S. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46144-3.00024-6 · Cited by 6
Optimization of Arginine Deaminase Production from Indigenous Bacterium Pseudomonas aeruginosa PS2
Sharma, A., Bala, K., & Husain, I. (2017) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2017.611.424 · Cited by 6
Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models
Kochavi, A., Velds, A., Suzuki, M., Akichika, S., Suzuki, T., Beijersbergen, R. L., & Agami, R. (2025) · NAR Cancer · doi:10.1093/narcan/zcaf044 · Cited by 5
Zhang, Q., Ding, L., Yan, Y., Zhai, Q., Guo, Z., Li, Y., Tang, Z., Zang, P., Ni, C., Zhang, S., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110415 · Cited by 5
Translating Metabolic Reprogramming into New Targets for Kidney Cancer
Aboud, O. A., & Weiss, R. H. (2017) · Kidney Cancer · doi:10.3233/kca-170014 · Cited by 5
Guanidine-Modifying Enzymes in the Pentein Superfamily
Linsky, T. W., & Fast, W. L. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00170-2 · Cited by 5
Calderón‐Montaño, J. M., Guillén-Mancina, E., Jiménez‐Alonso, J. J., Jiménez-González, V., Burgos‐Morón, E., Mate, A., Pérez-Guerrero, M. C., & López‐Lázaro, M. (2022) · Preprints.org · doi:10.20944/preprints202208.0088.v1 · Cited by 5
The Heterogeneity Metabolism of Renal Cell Carcinomas
Zarisfi, M., Nguyen, T. A., Nedrow, J. R., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_8 · Cited by 5
Barker, D. W., & Zagoria, R. J. (2005) · Medical radiology · doi:10.1007/3-540-30003-1_7 · Cited by 4
Zou, C., Wang, Y. J., Chen, Q., Shi, J., Wu, X., & Luo, Q. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1745024 · Cited by 3
Metabolic Reprogramming in Cancer
Prusty, D., & Manna, S. K. (2022) · Wiley eBooks · doi:10.1002/9781119851042.ch25 · Cited by 3
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2024) · eLife · doi:10.7554/elife.95652.3 · Cited by 3
Zhang, W., Qiao, X., Xie, T., Cai, W., Zhang, X., Chen, C., & Zhang, Y. (2022) · Antioxidants · doi:10.3390/antiox12010081 · Cited by 3
Chen, Y., He, J., Jin, T., Zhang, Y., & Ou, Y. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05280-2 · Cited by 2
Enzymes in oncohematology: relevant directions of experimental studies and prospects of clinical use
Pokrovskiy, V. S., & Трещалина, Е. М. (2014) · Clinical oncohematology · doi:10.21320/2500-2139-2014-7-1-28-38 · Cited by 2
Dual Role of Nitric Oxide in Tumor Immunity and Its Therapeutic Application
Kang, X., & Li, H. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl46222 · Cited by 1
Tumor Metabolism: Challenges and Future Perspectives
da Silva, E. L., Montenegro, R. C., & Moreira-Nunes, C. A. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_103-1 · Cited by 3
Targeting Argininosuccinate Synthetase in Cancer Therapy
Savaraj, N., You, M., Wu, C., Kuo, M. T., Dinh, V., Wangpaichitr, M., & Feun, L. G. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0730-0_3 · Cited by 1
OPTIMIZED PRODUCTION OF L-ARGINASE: A TUMOUR INHIBITOR ISOLATED FROM MARINE BACTERIA
Unissa, R., Mokenapelli, S., & Reddy, A. S. K. (2015) · International Journal of Pharma and Bio Sciences · Cited by 1
Zhang, P., & Ro, J. Y. (2018) · annals of urologic oncology · doi:10.32948/auo.2018.11.1 · Cited by 1
Arginine Deiminase and Cancer Therapy
Feun, L. G., Kuo, M. T., You, M., Wu, C. J., Wangpaichitr, M., & Savaraj, N. (2010) · doi:10.1002/9780470626528.ch9 · Cited by 1
ACTIVIDAD DE ARGINASA COMO UN MARCADOR DE CANCER DE MAMA EN PACIENTES MEXICANOS
Rodriguez, G. P. (2012) · REMERI - Red Mexicana de Repositorios Institucionales
Influence of immunological nutrition on treatment of patients with oncological profile
Катриченко, М. О., & Lisnyi, I. I. (2018) · Perioperaciina Medicina · doi:10.31636/prmd.v1i1.3
Madan, N., & Weiss, R. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-54945-5.00034-5
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.24.573250
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2024) · eLife · doi:10.7554/elife.95652.1
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2024) · eLife · doi:10.7554/elife.95652.2
Metabolic Reprogramming of Clear Cell Renal Cell Carcinoma and Its Clinical Significance
周, 文. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451486
Liu, Y., He, J., Lyu, D., Yang, X., Zhang, H., Tu, S., Yao, Y., Wei, M., Li, Y., Zhao, Z., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1537805
Tumor Metabolism: Challenges and Future Perspectives
da Silva, E. L., Montenegro, R. C., & Moreira-Nunes, C. A. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_103
Taki, F., Farhat, M. H., Atat, O. E., Al-Samman, S., Assaf, N., & Abi‐Habib, R. J. (2026) · Human Cell · doi:10.1007/s13577-026-01370-8
Liu, X., Zhang, M., Zhao, Y., Dai, Y., Han, C., Chen, J., Sun, H. S., Guo, Z., Qi, F., Zhang, Y., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03434-w
Abdelkhalek, M., El-Jawhari, Y., Shaheen, M., Saad, R., Sarieddine, M., El-Husseini, N., El‐Sibai, M., & Abi‐Habib, R. J. (2026) · CNS Oncology · doi:10.1080/20450907.2026.2666026
Li, M., Zhang, J., Zhang, H., Chen, X., Zou, X., Wang, J., Huang, W., Peng, H., Jia, H., & Hou, Z. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117621
Bacterial metabolic–immune reprogramming in cancer: from living vectors to engineered biofactories
Wu, J., Xu, L., Chen, Q., Yu, L., Liu, Z., & Xia, A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115394
Metadata
- Authors
- Yoon, C., Shim, Y., Kim, E., Lee, J., Won, N., Kim, J., Park, I., Yoon, D., & Min, B.
- Affiliations
- Korea University (KR)
- Seoul National University (KR)
- Inha University (KR)
- Corresponding author
- Min, Bon‐Hong
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-12-27
- Volume
- 120
- Issue
- 4
- Pages
- 897-905
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1983116683
- Cited by
- 165
- References
- 37
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 9 · 2023: 9 · 2022: 7 · 2021: 9 · 2020: 9 · 2019: 9 · 2018: 9 · 2017: 11 · 2016: 8 · 2015: 7 · 2014: 10 · 2013: 8 · 2012: 10
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (A050252)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Keywords
- renal cell carcinoma, argininosuccinate synthetase, arginine deiminase, arginine deprivation, tumor growth inhibition, tumor angiogenesis, vascular endothelial growth factor, neovascularization, proximal tubule, Renca cells, cancer therapy
- MeSH terms
- Adult, Aged, Animals, Arginase, Arginine, Argininosuccinate Synthase, Carcinoma, Renal Cell, Citrulline, Female, Humans, Hydrolases, Kidney Neoplasms, Male, Mice, Inbred BALB C, Middle Aged, Neovascularization, Pathologic, Polyethylene Glycols, Tumor Cells, Cultured, Survival Rate, Xenograft Model Antitumor Assays, Vascular Endothelial Growth Factor A, Cell Growth Processes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
